This course explores the critical intersection between nanotechnology and infectious pulmonary diseases. The program is divided into two phases:
- Theoretical Phase (5 weeks): In-depth study of nanocarriers (liposomes, polymeric, lipid nanoparticles…), aerosol physics, and pulmonary biological barriers (mucus, macrophages). A special focus is placed on the pathophysiology of bacterial biofilms and resistance mechanisms.
- Seminar Phase (3 weeks): “Journal Club” sessions and project presentations where students design innovative nanotechnological solutions to address real-world clinical challenges. The course adopts a “research-led teaching” approach, allowing students to engage with cutting-edge concepts derived from current doctoral research.


